4//SEC Filing
Quirk Michael C. 4
Accession 0001562180-25-003113
CIK 0001597553other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:09 PM ET
Size
11.7 KB
Accession
0001562180-25-003113
Insider Transaction Report
Form 4
Quirk Michael C.
See Remarks
Transactions
- Award
Common Stock
2025-04-10+933→ 30,041 total - Award
Common Stock
2025-04-10+1,269→ 30,998 total - Tax Payment
Common Stock
2025-04-10$6.91/sh−312$2,156→ 29,729 total - Tax Payment
Common Stock
2025-04-10$6.91/sh−424$2,930→ 30,574 total
Footnotes (2)
- [F1]On February 11, 2022, the reporting person was granted Performance Restricted Stock Units (PSUs) to acquire a total of 2,666 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 933 shares.
- [F2]On October 3, 2022, the reporting person was granted PSUs to acquire a total of 3,625 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 1,269 shares.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0002063117
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:09 PM ET
- Size
- 11.7 KB